-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Bionik Laboratories Corp. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q2 2022.
- Bionik Laboratories Corp. Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2022 was -$1.16M, a 88.1% decline year-over-year.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$3.39M, a 18.3% increase from 2021.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$4.15M, a 10.3% increase from 2020.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$4.62M, a 49% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)